"Carcinoma, Renal Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Descriptor ID |
D002292
|
| MeSH Number(s) |
C04.557.470.200.025.390 C04.588.945.947.535.160 C12.758.820.750.160 C12.777.419.473.160 C13.351.937.820.535.160 C13.351.968.419.473.160
|
| Concept/Terms |
Carcinoma, Renal Cell- Carcinoma, Renal Cell
- Carcinomas, Renal Cell
- Renal Cell Carcinomas
- Adenocarcinoma, Renal Cell
- Adenocarcinomas, Renal Cell
- Renal Cell Adenocarcinoma
- Renal Cell Adenocarcinomas
- Adenocarcinoma Of Kidney
- Adenocarcinoma Of Kidneys
- Kidney, Adenocarcinoma Of
- Kidneys, Adenocarcinoma Of
- Renal Cell Cancer
- Cancer, Renal Cell
- Cancers, Renal Cell
- Renal Cell Cancers
- Adenocarcinoma, Renal
- Adenocarcinomas, Renal
- Renal Adenocarcinoma
- Renal Adenocarcinomas
- Nephroid Carcinoma
- Carcinoma, Nephroid
- Carcinomas, Nephroid
- Nephroid Carcinomas
- Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma- Clear Cell Renal Cell Carcinoma
- Grawitz Tumor
- Tumor, Grawitz
- Clear Cell Renal Carcinoma
- Carcinoma, Hypernephroid
- Carcinomas, Hypernephroid
- Hypernephroid Carcinoma
- Hypernephroid Carcinomas
- Hypernephroma
- Hypernephromas
Collecting Duct Carcinoma (Kidney)- Collecting Duct Carcinoma (Kidney)
- Carcinoma, Collecting Duct (Kidney)
- Carcinomas, Collecting Duct (Kidney)
- Collecting Duct Carcinomas (Kidney)
- Collecting Duct Carcinoma of the Kidney
- Renal Collecting Duct Carcinoma
- Collecting Duct Carcinoma
- Carcinoma, Collecting Duct
- Carcinomas, Collecting Duct
- Collecting Duct Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Renal Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Renal Cell".
This graph shows the total number of publications written about "Carcinoma, Renal Cell" by people in this website by year, and whether "Carcinoma, Renal Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 3 | 0 | 3 |
| 1998 | 3 | 0 | 3 |
| 1999 | 1 | 0 | 1 |
| 2000 | 4 | 0 | 4 |
| 2001 | 2 | 3 | 5 |
| 2002 | 5 | 0 | 5 |
| 2003 | 3 | 1 | 4 |
| 2004 | 10 | 1 | 11 |
| 2005 | 5 | 2 | 7 |
| 2006 | 12 | 1 | 13 |
| 2007 | 6 | 1 | 7 |
| 2008 | 11 | 0 | 11 |
| 2009 | 7 | 0 | 7 |
| 2010 | 6 | 2 | 8 |
| 2011 | 5 | 2 | 7 |
| 2012 | 5 | 0 | 5 |
| 2013 | 9 | 2 | 11 |
| 2014 | 11 | 3 | 14 |
| 2015 | 11 | 1 | 12 |
| 2016 | 19 | 0 | 19 |
| 2017 | 8 | 1 | 9 |
| 2018 | 10 | 2 | 12 |
| 2019 | 10 | 1 | 11 |
| 2020 | 10 | 2 | 12 |
| 2021 | 11 | 3 | 14 |
| 2022 | 8 | 0 | 8 |
| 2023 | 4 | 0 | 4 |
| 2024 | 11 | 0 | 11 |
| 2025 | 12 | 0 | 12 |
| 2026 | 8 | 0 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Renal Cell" by people in Profiles.
-
Mitochondrial potential reflects T cell fitness and function during cancer immunotherapy. J Immunol. 2026 Jun 07; 215(6).
-
Updates and controversies in contemporary grading of clear cell renal cell carcinoma and papillary renal cell carcinoma. Histopathology. 2026 Oct; 89(4):574-589.
-
Association of genomic driver mutation, histologic subtype, and mTORC1 biomarker expression in mTOR pathway-altered renal tumors. Hum Pathol. 2026 Sep; 175:106154.
-
Comprehensive analysis of six MED15::TFE3 renal cell carcinomas including two novel solid MED15::TFE3 renal cell carcinomas, highlighting their morphologic, immunohistochemical and molecular differences from their cystic counterparts. Virchows Arch. 2026 Sep; 489(3):669-680.
-
The Many Faces of TPM3::ALK Fusion Renal Cell Carcinoma: Case Report and Review of the Literature. Int J Surg Pathol. 2026 Aug; 34(5):1241-1246.
-
Monogenic and Polygenic Risk for Kidney Cancer in Two Large Biobanks. Eur Urol Oncol. 2026 Jun; 9(3):638-644.
-
Cytomorphologic and molecular characterization of metastatic renal cell carcinoma diagnosed by fine-needle biopsy: a single-institution study. J Am Soc Cytopathol. 2026 May-Jun; 15(3):197-206.
-
Percutaneous renal mass biopsies with no viable lesional cells - Recognizing different histologic patterns can help predict nondiagnostic vs. true negative biopsy and guide clinical management. Ann Diagn Pathol. 2026 Jun; 82:152607.
-
Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features. Histopathology. 2026 Apr; 88(5):1044-1050.
-
MTOR-mutated eosinophilic renal cell carcinomas with loss of chromosome 1 and high metastatic potential: further expanding the spectrum of TSC/mTOR pathway mutated renal tumors. Virchows Arch. 2026 Sep; 489(3):575-581.